Rosenberg's team transferred CD4+ T helper 1 cells, which could recognize a mutation in ERBB2IP expressed by tumor cells from a patient with metastatic cholangiocarcinoma, resulting in tumor regression [17]. This evidence concerns the gene CD4 and neoplasm.